Overview

Safety and Efficacy of Nemolizumab in PN

Status:
Completed
Trial end date:
2018-09-26
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the safety and efficacy of nemolizumab in subjects with prurigo nodularis.
Phase:
Phase 2
Details
Lead Sponsor:
Galderma R&D